MSH|^~\&|ADM|ARH|||202002031129||ADT^A08|4160141|D|2.2|||AL|NE
EVN|A08|202002031129||||
PID|1|FHATVIG0001302|AB00006970|AB6946|PCSTEST^FOURTEEN||19890630|M|||1234 Main St^^Surrey^BC^V3R 3Z3|||||||AB001931/17|9876412991
PV1|1|I|AB-3CHEAM^AB3C-C3010^1|EL|||OEDOCM^Oedoc^Marytrain^^^^MD^^^^^^XX|||MEDS||||||||IN|||||||||||||||||||||ARH|||||201712141223|
PV2||P^Private - Non-Solicited|ABD PAIN
OBX|1|ST|1010.1^WEIGHT^CPT4||0.150||||||F
OBX|2|ST|1010.3^HEIGHT^CPT4||25.0||||||F
OBX|3|TX|ADM AC AUD^HIGH PROFILE PATIENT - ACCESS AUDIT (Y)^ADM||N||||||F
OBX|4|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20161214||||||F
OBX|5|CE|ADM IDSOUR^SOURCE OF ID^ADM||BCC^BC CareCard (No Photo ID)||||||F
OBX|6|CE|ADM MDRO2^Canada in the last 12 months?^ADM||N^NO||||||F
OBX|7|CE|ADM MDRO4^Bangladesh or Vietnam in the last 12 months?^ADM||N^NO||||||F
OBX|8|CE|ADM MRSA2^correctional/shelter in the last 12 months?^ADM||N^NO||||||F
OBX|9|CE|AcADL00200^Mobility aids used prior to admission^ADM||10^Crutches axillary||||||F
OBX|10|CE|AcFTTYPE00^Footwear type^ADM||1^Non slip socks||||||F
OBX|11|CE|AcHEHT0M00^Home environment - housing type^ADM||1^House||||||F
OBX|12|CE|AcHOCNPR00^Housing considerations prior to admission^ADM||1^Stairs||||||F
OBX|13|TX|AcNEOBA000^Bath date^ADM||20180728||||||F
OBX|14|TX|AcNEOBA010^Bath next due^ADM||20180730||||||F
OBX|15|CE|AcSTAM0002^State^ADM||5^Active alert||||||F
OBX|16|CE|AcTOASST02^Toileting assistance^ADM||1^Unassisted||||||F
OBX|17|CE|Ad00001000^Lines/Tubes in situ^ADM||5^PIV||||||F
OBX|18|TX|Ad00002000^Two patient identifiers checked^ADM||Y||||||F
OBX|19|CE|Ad00002100^Handover performed by^ADM||1^In person||||||F
OBX|20|TX|Ad00002200^Handover performed by other^ADM||tape report||||||F
OBX|21|TX|Ad00002800^Caregiver(s) vocational/financial status^ADM||employed full time||||||F
OBX|22|TX|AdAC000100^Accompanied by other^ADM||Mom, Sarah||||||F
OBX|23|TX|AdADMDAT01^Admission date^ADM||20180904||||||F
OBX|24|CE|AdADMFRO01^Admitted from^ADM||2^Home||||||F
OBX|25|TX|AdADMIPB00^Any travel to India Pakistan or Bangladesh in last 12 months^ADM||N||||||F
OBX|26|TX|AdADMOUT01^Any healthcare encounter outside Canada in last 12 months^ADM||N||||||F
OBX|27|TX|AdADMRSN00^Reason for admission^ADM||preterm, low birth weight||||||F
OBX|28|TX|AdADMSIX00^Admitted to care area in the last 6 months^ADM||N||||||F
OBX|29|TX|AdADMTIM00^Admission time^ADM||1515||||||F
OBX|30|TX|AdALLERB00^Allergy band checked^ADM||Y||||||F
OBX|31|TX|AdALLERR00^Allergies reviewed^ADM||Y||||||F
OBX|32|CE|AdARRMOD00^Mode of arrival^ADM||3^Walking||||||F
OBX|33|CE|AdARRMOD01^Mode of arrival^ADM||9^Cot||||||F
OBX|34|CE|AdBIRTH000^Birth place^ADM||1^Hospital||||||F
OBX|35|TX|AdBIRTH010^Expected date of delivery^ADM||20180730||||||F
OBX|36|CE|AdBIRTH020^Delivery presentation^ADM||1^Cephalic||||||F
OBX|37|CE|AdBIRTH030^Single/Multiple births^ADM||1^Singleton||||||F
OBX|38|CE|AdBIRTH040^Birth gender^ADM||2^Female||||||F
OBX|39|TX|AdBIRTH060^Meconium present at delivery^ADM||N||||||F
OBX|40|CE|AdBIRTH070^Substance exposure^ADM||1^Tobacco||||||F
OBX|41|CE|AdBIRTH100^Group B Strep exposure^ADM||1^Yes||||||F
OBX|42|TX|AdBIRTH110^Group B Strep prophylaxis followed^ADM||Y||||||F
OBX|43|CE|AdBIRTH120^Hepatitis B exposure^ADM||2^No||||||F
OBX|44|TX|AdCARELB00^Caregiver language barrier^ADM||N||||||F
OBX|45|CE|AdCCCARE01^Level of care^ADM||5^3a||||||F
OBX|46|CE|AdCSUM0000^Community supports utilized prior to admission^ADM||1^None||||||F
OBX|47|TX|AdCULREQ01^Cultural/Spiritual considerations^ADM||N||||||F
OBX|48|CE|AdDISCHA00^Destination^ADM||1^Home||||||F
OBX|49|TX|AdESTDTD00^Estimated date of discharge^ADM||20180802||||||F
OBX|50|TX|AdESTPTF00^Patient/Family informed of estimated date of discharge^ADM||Y||||||F
OBX|51|CE|AdESTREA03^Reason EDD changed^ADM||1^Acuity||||||F
OBX|52|TX|AdFUAPCO03^Services and appointments arranged comments^ADM||Outpatient peds clinic referral||||||F
OBX|53|CE|AdFUAPPT02^Follow-up appointments arranged^ADM||2^Outpatient||||||F
OBX|54|TX|AdHXALLE00^Hx of unexplained allergic reaction during medical procedure^ADM||N||||||F
OBX|55|TX|AdHXCOND00^History of presenting condition^ADM||preterm||||||F
OBX|56|TX|AdHXITCH00^Hx of itchiness/swelling post dental, rectal or pelvic exam^ADM||N||||||F
OBX|57|TX|AdHXSBIF00^Hx of Spina Bifida^ADM||N||||||F
OBX|58|TX|AdINFNAM00^Name of information source^ADM||Bill||||||F
OBX|59|CE|AdINSM0000^Information source^ADM||2^Parent(s)~10^Nurse||||||F
OBX|60|TX|AdINTNEE00^Interpreter needed^ADM||N||||||F
OBX|61|TX|AdMRPNAM00^MRP or physician name^ADM||Dr. Blue||||||F
OBX|62|TX|AdNAMEBN00^Name band on^ADM||Y||||||F
OBX|63|CE|AdNEWBO041^Abdomen defined parameters^ADM||2^Significant findings||||||F
OBX|64|CE|AdNEWBO281^Current behaviour^ADM||9^Irritable||||||F
OBX|65|CE|AdNEWBO300^Crying^ADM||3^Weak cry||||||F
OBX|66|TX|AdNICUA110^Central capillary refill^ADM||2||||||F
OBX|67|TX|AdNICUA120^Peripheral capillary refill^ADM||3||||||F
OBX|68|CE|AdNICUA130^General skin appearance^ADM||4^Pink||||||F
OBX|69|CE|AdNICUA180^Overall muscle tone^ADM||3^Hypotonic||||||F
OBX|70|CE|AdNICUAD11^Admitted bed type^ADM||1^Incubator||||||F
OBX|71|TX|AdNICUAD30^Initial stool^ADM||N||||||F
OBX|72|TX|AdNICUAD40^Initial void^ADM||Y||||||F
OBX|73|TX|AdNICUAD50^MRSA initial screening date^ADM||20180801||||||F
OBX|74|TX|AdNICUAD60^MRSA repeat screening needed^ADM||Y||||||F
OBX|75|TX|AdNICUAD70^MRSA repeat screening date^ADM||Aug 15, 2018||||||F
OBX|76|CE|AdNICUAD80^Admitted from^ADM||1^Maternity||||||F
OBX|77|CE|AdNICUAD90^Additional warming techniques^ADM||1^Warming mattress||||||F
OBX|78|TX|AdNOKIDA00^Next of kin/individual notified date^ADM||20180820||||||F
OBX|79|TX|AdNOKINA00^Name of next of kin/individual notified^ADM||Mrs. PCSTEST||||||F
OBX|80|TX|AdNOKITI00^Next of kin/individual notified time^ADM||1025||||||F
OBX|81|TX|AdNOKNOT02^Next of kin/individual notified^ADM||Y||||||F
OBX|82|CE|AdONGOI061^Umbilicus defined parameters^ADM||1^Within defined parameters||||||F
OBX|83|CE|AdONGOI071^Skin defined parameters^ADM||2^Significant findings||||||F
OBX|84|CE|AdONGOI090^Skeletal/Extremities defined parameters^ADM||1^Within defined parameters||||||F
OBX|85|CE|AdONGOI190^Neuromuscular defined parameters^ADM||1^Within defined parameters||||||F
OBX|86|CE|AdONGOI260^Genitalia defined parameters^ADM||2^Significant findings||||||F
OBX|87|CE|AdONGOI270^Behaviour defined parameters^ADM||2^Significant findings||||||F
OBX|88|CE|AdONGOIN02^Cardiorespiratory defined parameters^ADM||1^Within defined parameters||||||F
OBX|89|TX|AdPLACEC00^Lines/Tubes placement confirmed with physician^ADM||Y||||||F
OBX|90|TX|AdPRLANG00^Primary language spoken^ADM||english||||||F
OBX|91|CE|AdPTA00000^Mechanical equipment used prior to admission^ADM||1^Stair lift||||||F
OBX|92|CE|AdPTA05600^Diet type prior to admission^ADM||1^General||||||F
OBX|93|TX|AdPTA14000^Sleep pattern prior to admission^ADM||adequate and appropriate for age||||||F
OBX|94|CE|AdREPREF00^Report received^ADM||1^In person||||||F
OBX|95|TX|AdREPRFR01^Report received from^ADM||Bill, RN||||||F
OBX|96|CE|AdSERVAR00^Services arranged^ADM||1^None required||||||F
OBX|97|TX|AdTWPAID01^Two patient identifiers checked^ADM||Y||||||F
OBX|98|CE|Ca00000100^Right radial pulse^ADM||9^Normal||||||F
OBX|99|CE|Ca00000200^Right ulnar pulse^ADM||9^Normal||||||F
OBX|100|CE|Ca00000300^Right brachial pulse^ADM||9^Normal||||||F
OBX|101|CE|Ca00000400^Left radial pulse^ADM||9^Normal||||||F
OBX|102|CE|Ca00000500^Left ulnar pulse^ADM||10^Bounding||||||F
OBX|103|CE|Ca00000600^Left brachial pulse^ADM||12^Strong||||||F
OBX|104|CE|Ca00000700^Right dorsalis pedis pulse^ADM||9^Normal||||||F
OBX|105|CE|Ca00000800^Right post tibial pulse^ADM||11^Weak||||||F
OBX|106|CE|Ca00000900^Right popliteal pulse^ADM||9^Normal||||||F
OBX|107|CE|Ca00001000^Left dorsalis pedis pulse^ADM||10^Bounding||||||F
OBX|108|CE|Ca00001100^Left post tibial pulse^ADM||9^Normal||||||F
OBX|109|CE|Ca00001200^Left popliteal pulse^ADM||11^Weak||||||F
OBX|110|CE|Ca00001300^Right femoral pulse^ADM||10^Bounding||||||F
OBX|111|CE|Ca00001400^Left femoral pulse^ADM||12^Strong||||||F
OBX|112|TX|Ca00001500^Pulse strength^ADM||||||||F
OBX|113|TX|Ca00001600^Capillary refill^ADM||||||||F
OBX|114|CE|CaCCHD0131^Screening number^ADM||3^3||||||F
OBX|115|TX|CaCCHD0140^Pulse oximetry right hand^ADM||95||||||F
OBX|116|TX|CaCCHD0150^Pulse oximetry either foot^ADM||94||||||F
OBX|117|TX|CaCCHD0160^Difference between pulse oximetry^ADM||1||||||F
OBX|118|TX|CaCCHD0172^Screening outcome^ADM||Fail||||||F
OBX|119|TX|CaCWCOLO01^CWMS colour^ADM||||||||F
OBX|120|CE|CaEDEMA000^Edema^ADM||2^Present||||||F
OBX|121|TX|CaHS000300^Heart sounds murmur^ADM||N||||||F
OBX|122|CE|CaHS000700^Heart sounds audible^ADM||1^S1~3^S2||||||F
OBX|123|CE|CaPED00200^Capillary refill central^ADM||2^3 seconds||||||F
OBX|124|CE|CaPED00300^Capillary refill right hand^ADM||3^4 seconds||||||F
OBX|125|CE|CaPED00400^Capillary refill left hand^ADM||4^Greater/Equal 5 seconds||||||F
OBX|126|CE|CaPED00600^Capillary refill left foot^ADM||1^1-2 seconds||||||F
OBX|127|TX|CaPLDATE00^PIV Insertion date^ADM||20180801||||||F
OBX|128|TX|CmCARLAN00^Caregiver primary language^ADM||english||||||F
OBX|129|TX|CmMRPAWR01^MRP or physician aware^ADM||Y||||||F
OBX|130|CE|CmMRPCME01^MRP or physician communication method^ADM||1^In person||||||F
OBX|131|TX|CmMRPCOC01^MRP or physician communication outcome^ADM||Dr. Blue will come and assess hip||||||F
OBX|132|TX|CmMRPCTI01^MRP or physician communication time^ADM||1024||||||F
OBX|133|TX|CmOSPEOO00^Other speech observations via other^ADM||TEST||||||F
OBX|134|CE|CmOSPEOV00^Other speech observations via^ADM||3^Sounds~6^Standardized Ax tool~9^Reading||||||F
OBX|135|TX|EnGLYC0000^Glucometer blood glucose^ADM||4.0||||||F
OBX|136|CE|Gi00000701^Bowel movement consistency^ADM||1^Soft||||||F
OBX|137|TX|Gi00001000^Bowel pattern prior to admission^ADM||regular||||||F
OBX|138|CE|GiABPALP02^Abdominal palpation^ADM||1^Soft||||||F
OBX|139|CE|GiABSHAP00^Abdominal shape^ADM||1^Flat||||||F
OBX|140|CE|GiANATO102^Gastrointestinal anomalies^ADM||2^Gastroschesis||||||F
OBX|141|CE|GiBM000000^Bowel movement method^ADM||1^Toilet||||||F
OBX|142|CE|GiBM000100^Bowel movement colour^ADM||3^Brown||||||F
OBX|143|CE|GiBMAMT201^Bowel movement amount^ADM||7^Small||||||F
OBX|144|TX|GiBMINCO00^Bowel movement incontinence^ADM||N||||||F
OBX|145|TX|GiBO000301^Last bowel movement date as reported by patient^ADM||20181221||||||F
OBX|146|TX|GiBO000302^Last bowel movement date as reported by patient^ADM||20180801||||||F
OBX|147|CE|GiBOFLAT00^Bowel flatus present^ADM||2^Present||||||F
OBX|148|TX|GiBOTTLE01^Intake, Bottle Feeding Amount^ADM||12.5||||||F
OBX|149|CE|GiBSACTI01^Bowel sounds active in all four quadrants^ADM||1^Yes||||||F
OBX|150|TX|GiBSACTI02^Bowel sounds active in all 4 quadrants^ADM||Y||||||F
OBX|151|TX|GiENTINS01^Initial tube length^ADM||2.0||||||F
OBX|152|TX|GiETINDA00^Insertion date^ADM||20180801||||||F
OBX|153|TX|GiETINTI00^Enteral feeding tube insertion time^ADM||0929||||||F
OBX|154|TX|GiETSIZE00^Enteral feeding tube size^ADM||3.0||||||F
OBX|155|TX|GiHGSYEV00^Hypoglycemia symptoms evident^ADM||N||||||F
OBX|156|CE|GiNICU0080^Insertion site^ADM||1^Right nare||||||F
OBX|157|TX|Gu00000100^Voiding pattern prior to admission^ADM||no concerns||||||F
OBX|158|CE|GuBDPAT001^Bladder pattern^ADM||1^Normal||||||F
OBX|159|CE|GuBDVM0002^Voiding method^ADM||1^Toilet||||||F
OBX|160|CE|GuGTCID001^Genitalia concerns identified^ADM||2^Rt inguinal hernia||||||F
OBX|161|CE|GuUC000100^Urinary catheter insertion reason^ADM||1^Retention||||||F
OBX|162|CE|GuUCACU000^Urinary catheter antiseptic cleansing agent used^ADM||1^Chlorhexidine (CHG) 0.05%||||||F
OBX|163|TX|GuUCBFV000^Urinary catheter balloon fill volume^ADM||10||||||F
OBX|164|CE|GuUCBSZ002^Urinary catheter balloon size^ADM||3^10 cc||||||F
OBX|165|TX|GuUCID0000^Urinary catheter insertion date^ADM||20180802||||||F
OBX|166|TX|GuUCIT0000^Urinary catheter insertion time^ADM||0943||||||F
OBX|167|CE|GuUCMAT000^Urinary catheter material^ADM||1^Latex||||||F
OBX|168|TX|GuUCNIA000^Urinary catheter insertion attempts^ADM||1||||||F
OBX|169|TX|GuUCRDT000^Urinary catheter removal date^ADM||20180802||||||F
OBX|170|TX|GuUCSZA002^Urinary catheter size^ADM||12||||||F
OBX|171|CE|GuUCTAU001^Urinary catheter topical anesthetic used^ADM||1^Lidocaine Jelly (2%)||||||F
OBX|172|CE|GuUCTL0002^Urinary catheter type/location^ADM||1^Straight (In and Out)||||||F
OBX|173|CE|GuUCUCS000^Urinary collection system^ADM||1^Drainage bag||||||F
OBX|174|CE|GuURCLR000^Urine clarity^ADM||1^Clear||||||F
OBX|175|CE|GuURCOL002^Urine colour^ADM||1^Yellow||||||F
OBX|176|CE|GuUROD0000^Urine odour^ADM||1^None||||||F
OBX|177|CE|He00000001^Anterior cranial sutures^ADM||1^Approximated||||||F
OBX|178|CE|He00000101^Posterior cranial sutures^ADM||2^Overriding||||||F
OBX|179|CE|He00000200^Anterior fontanelle^ADM||1^Soft||||||F
OBX|180|CE|He00000400^Posterior fontanelle^ADM||1^Soft||||||F
OBX|181|TX|HeAXMEUC00^Assessment method used comment^ADM||TEST||||||F
OBX|182|CE|HeAXPAR001^Assessment participation^ADM||1^No concerns||||||F
OBX|183|TX|HeAXPARC01^Assessment participation comments^ADM||TESET||||||F
OBX|184|TX|HeAXPARO01^Assessment participation other^ADM||TEST||||||F
OBX|185|CE|HeEY000600^Sclera colour^ADM||1^White||||||F
OBX|186|CE|HeEY001001^Eye discharge description^ADM||1^Clear||||||F
OBX|187|CE|HeNO000200^Nasal septum^ADM||1^Midline||||||F
OBX|188|CE|HeNO000601^Nose discharge consistency^ADM||1^Thin||||||F
OBX|189|CE|HeNO000701^Nasal discharge description^ADM||2^Serous||||||F
OBX|190|CE|HeNOSEDR00^Nose drainage amount^ADM||3^Small||||||F
OBX|191|CE|HeSL014001^Voice Motor CN10 quality^ADM||2^Aphonic~3^Rough/Hoarse~4^Tremulous~5^Breathy~9^Weak||||||F
OBX|192|TX|HeSL014101^Voice Motor CN10 quality other^ADM||TEST||||||F
OBX|193|TX|HeSL016800^Phonation comment^ADM||TESt||||||F
OBX|194|CE|HeTR000100^Trachea position^ADM||3^Deviated right||||||F
OBX|195|TX|HeTYAXME00^Standardized assessment tool used^ADM||TESTE||||||F
OBX|196|TX|HxABXMAT02^Antibiotics used in intrapartum period^ADM||N||||||F
OBX|197|TX|HxADH00100^Using contraception^ADM||Y||||||F
OBX|198|TX|HxADH00200^Menstruating^ADM||Y||||||F
OBX|199|TX|HxADH00300^Previous history of STI's^ADM||N||||||F
OBX|200|TX|HxADH00400^Previous or current smoker^ADM||Y||||||F
OBX|201|TX|HxADH00500^Previous or current alcohol and/or drug use^ADM||N||||||F
OBX|202|TX|HxANAMAT01^Analgesics used in intrapartum period^ADM||N||||||F
OBX|203|TX|HxCORAGE10^Corrected age^ADM||Use PMA||||||F
OBX|204|TX|HxIIDATE01^Date of birth^ADM||20180727||||||F
OBX|205|TX|HxIIGAWD00^Gestational age^ADM||0 weeks 3 days||||||F
OBX|206|TX|HxIIGEDA00^Gestational age in days^ADM||3||||||F
OBX|207|TX|HxIIGEWE00^Gestational age in weeks^ADM||0||||||F
OBX|208|TX|HxIISCO100^Apgar score at 1 min^ADM||5||||||F
OBX|209|TX|HxIISCO200^Apgar score at 5 mins^ADM||6||||||F
OBX|210|TX|HxIISCO300^Apgar score at 10 mins^ADM||7||||||F
OBX|211|TX|HxIITIME00^Infant time of birth^ADM||1500||||||F
OBX|212|TX|HxIMMUTD00^Immunizations up to date^ADM||Y||||||F
OBX|213|TX|HxMEASUR00^Weight change from previous measurement^ADM||100 grams over the past 0 days||||||F
OBX|214|TX|HxMEASUR10^Percent weight change since birth^ADM||5.00%  weight gain||||||F
OBX|215|TX|HxMRSAMD00^MRSA/MDRO swabs completed^ADM||N||||||F
OBX|216|TX|HxSCH00000^School currently enrolled in^ADM||Abby Senior Sec||||||F
OBX|217|TX|HxSCH00100^Current grade^ADM||11||||||F
OBX|218|TX|HxSPTCHX00^Summary of patient's clinical history^ADM||asthama, no other significant medical history||||||F
OBX|219|CE|InBABABY01^Bathed by^ADM||1^Nurse||||||F
OBX|220|TX|InBATHDE00^Bath deferred^ADM||N||||||F
OBX|221|CE|InBATHME00^Bath method^ADM||2^Sponge||||||F
OBX|222|CE|InBSACTV00^Braden Scale activity^ADM||3^3-Walks occasionally||||||F
OBX|223|CE|InBSFRSH00^Braden Scale friction and shear^ADM||1^1-Problem||||||F
OBX|224|CE|InBSMOBI01^Braden Scale mobility^ADM||1^1-Completely immobile||||||F
OBX|225|CE|InBSMOIS00^Braden Scale moisture^ADM||1^1-Constantly moist||||||F
OBX|226|CE|InBSNUTR00^Braden Scale nutrition^ADM||2^2-Probably inadequate||||||F
OBX|227|CE|InBSRISK00^Braden Scale risk level^ADM||3^High||||||F
OBX|228|TX|InBSSCOR00^Braden Skin Risk Assessment Score^ADM||10||||||F
OBX|229|CE|InBSSPER00^Braden Scale sensory perception^ADM||2^2-Very limited||||||F
OBX|230|CE|InDREDRE00^External dressing drainage amount^ADM||1^None/scant||||||F
OBX|231|CE|InEDEMAS00^Edema severity^ADM||2^+2||||||F
OBX|232|CE|InEDEMLB01^Edema location^ADM||15^Up to knee||||||F
OBX|233|CE|InEDEMLM00^Edema location modifier^ADM||1^Bilateral||||||F
OBX|234|CE|InEDEMTP00^Edema type^ADM||2^Non-pitting||||||F
OBX|235|CE|InINA00100^Extremity/Extremities concerns^ADM||1^Extra digit right hand||||||F
OBX|236|TX|InINA00300^Extremity/Extremities concerns comments^ADM||extra pinky||||||F
OBX|237|TX|InINDRES00^Dressing dry and intact^ADM||Y||||||F
OBX|238|CE|InMMOT0000^Mucous membranes^ADM||1^Moist||||||F
OBX|239|TX|InPHOT0150^Transcutaneous bilirubin hours of age^ADM||48||||||F
OBX|240|TX|InPHOT0160^Transcutaneous bilirubin level^ADM||20||||||F
OBX|241|TX|InPTRESP00^Patient's response to procedure^ADM||happy||||||F
OBX|242|CE|InSKIAPP01^Skin appearance^ADM||2^Cyanotic~5^Jaundice||||||F
OBX|243|CE|InSKIDES03^Skin description^ADM||10^Birthmark||||||F
OBX|244|CE|InSKIMOD01^Skin and wound modifier^ADM||2^Right||||||F
OBX|245|CE|InSKIMOI02^Skin moisture^ADM||1^Dry||||||F
OBX|246|CE|InSKITEM00^Skin temperature^ADM||2^Warm||||||F
OBX|247|CE|InSKTURG00^Skin turgor^ADM||1^Turgor elastic||||||F
OBX|248|CE|InUCSTAT01^Umbilical cord status^ADM||1^Clamped||||||F
OBX|249|CE|InUCSTUM01^Umbilical cord description^ADM||1^Clean||||||F
OBX|250|CE|InWOULOC02^Skin or wound location^ADM||16^Buttock||||||F
OBX|251|TX|IoNICUIN20^Location^ADM||left arm||||||F
OBX|252|CE|IvIN000600^Glycemic management sample source^ADM||1^Capillary||||||F
OBX|253|CE|IvIN000700^Glycemic management insulin concentration^ADM||1^100 units in 100 mL||||||F
OBX|254|TX|IvIN000800^Glycemic management infusion dosage^ADM||3.0||||||F
OBX|255|TX|IvIN000901^Glycemic management infusion rate^ADM||3.0||||||F
OBX|256|TX|IvIN001201^Lab result reviewed and within 20% of bedside result^ADM||Y||||||F
OBX|257|CE|IvIN020200^Insulin route^ADM||1^Subcutaneous||||||F
OBX|258|TX|IvIN021400^IV Intake Amount^ADM||500||||||F
OBX|259|CE|IvININST00^Insulin infusion type^ADM||1^Regular||||||F
OBX|260|CE|IvINVLOC00^Location^ADM||3^Hand||||||F
OBX|261|CE|IvINVTYP01^Line type^ADM||1^PIV||||||F
OBX|262|CE|IvLOCATM00^Location modifier^ADM||1^Right||||||F
OBX|263|CE|IvLOCATM01^Location Modifier^ADM||1^Right||||||F
OBX|264|CE|IvPIVLOC00^Location^ADM||7^Scalp PIV||||||F
OBX|265|TX|IvPIVNIC00^PIV insertion time^ADM||0930||||||F
OBX|266|CE|IvPL000700^Initial management^ADM||2^Saline lock||||||F
OBX|267|TX|IvRATE0000^Rate^ADM||5.00||||||F
OBX|268|TX|IvSIZE0000^Size^ADM||8||||||F
OBX|269|TX|IvSOLINF00^Solution infusing^ADM||NS||||||F
OBX|270|CE|MhLOBMT001^Level of observation maintained^ADM||1^Level 1||||||F
OBX|271|CE|MoAIDUSE00^Aid used for independent ambulation^ADM||1^Standard walker||||||F
OBX|272|CE|MoAMASTN02^Assistance required for ambulation^ADM||3^1 person assist||||||F
OBX|273|CE|MoAMBABI00^Ambulation ability^ADM||2^Independent with aid||||||F
OBX|274|CE|MoAMMBAD00^Mobility aid used for ambulation^ADM||1^Standard walker||||||F
OBX|275|CE|MoAMRMWD00^Ambulation^ADM||1^Within room||||||F
OBX|276|TX|MoCHTIME00^Duration of time up in chair^ADM||1.0||||||F
OBX|277|CE|MoFALPRE00^Fall prevention strategy^ADM||1^Fall Precautions/SAFE||||||F
OBX|278|CE|MoTFCAST03^Assistance required for transfer^ADM||2^Supervision||||||F
OBX|279|CE|MoTFCHAD00^Mobility aid used for transfer to chair^ADM||1^Standard walker||||||F
OBX|280|CE|MoTRANST00^Transfer to^ADM||1^Chair||||||F
OBX|281|CE|MoWC001800^Shoulder position^ADM||1^Level||||||F
OBX|282|TX|MoWC001900^Shoulder position other^ADM||TEST||||||F
OBX|283|CE|MoWC002101^Neck position^ADM||1^Neutral||||||F
OBX|284|TX|MoWC002401^Head control^ADM||TEST||||||F
OBX|285|CE|MsORTH0001^Supportive orthosis for mobilization^ADM||2^Back brace||||||F
OBX|286|CE|NeBEHAVI01^Current behaviour^ADM||1^Content||||||F
OBX|287|CE|NeCATLOC02^Altered level of consciousness^ADM||1^No||||||F
OBX|288|CE|NeCDIFFA01^Difficulty focusing attention^ADM||1^No||||||F
OBX|289|CE|NeCDIOFS02^Diagnosis of delirium suggested^ADM||2^Yes||||||F
OBX|290|TX|NeCDIORE00^CAM assessment^ADM||Complete||||||F
OBX|291|CE|NeCEACMS01^Evidence of acute change in mental status from baseline^ADM||1^No||||||F
OBX|292|CE|NeCFBDPD01^Fluctuating behaviour during the past day^ADM||1^No||||||F
OBX|293|CE|NeCSPDSI01^Speech disorganized or incoherent^ADM||2^Yes||||||F
OBX|294|TX|NeGLBLGU00^Glucometer blood glucose^ADM||4.5||||||F
OBX|295|TX|NeNICUN010^Location^ADM||||||||F
OBX|296|TX|NeNICUN020^Artery^ADM||||||||F
OBX|297|TX|NeNICUN110^Temperature^ADM||||||||F
OBX|298|TX|NePSFAPR10^Family present during procedural sedation^ADM||N||||||F
OBX|299|TX|NePSG00000^Procedural sedation given^ADM||Y||||||F
OBX|300|CE|NePSPER000^Personnel present during procedural sedation^ADM||1^Physician~2^RN||||||F
OBX|301|TX|NePSPERO00^Additional personnel present during procedural sedation^ADM||Med Student||||||F
OBX|302|TX|NePSPRO101^Procedural sedation type^ADM||3||||||F
OBX|303|CE|NePSSAFE00^Access to procedural sedation safety equipment^ADM||1^Patent IV~2^Reversal agents~3^Oral airway~4^Bag valve mask~5^Oxygen~6^Suction~7^Crash cart available||||||F
OBX|304|TX|NePSTIPC00^Time procedure completed^ADM||1100||||||F
OBX|305|TX|NePSTIPS00^Time procedure started^ADM||1028||||||F
OBX|306|TX|NePSTISS00^Time procedural sedation started^ADM||1028||||||F
OBX|307|TX|NePSTIVE00^Procedural sedation time out verification completed^ADM||Y||||||F
OBX|308|TX|NePSTRCR01^Procedural sedation transfer criteria met^ADM||Y||||||F
OBX|309|CE|NePUSIDE00^Pupil side^ADM||3^Bilateral||||||F
OBX|310|TX|NmORANAC00^Orofacial anatomical anomalies comment^ADM||left side||||||F
OBX|311|CE|NmORANAN01^Orofacial anatomical anomalies^ADM||3^Cleft lip||||||F
OBX|312|TX|NmPRECAR00^Prenatal care^ADM||Y||||||F
OBX|313|TX|Nu00000600^Parenteral nutrition core solution infusion rate^ADM||30.0||||||F
OBX|314|TX|Nu00000700^Parenteral nutrition lipid infusion rate^ADM||45||||||F
OBX|315|TX|Nu00000800^D10W infusion rate^ADM||50.0||||||F
OBX|316|CE|Nu00015500^Patient's position during breakfast^ADM||1^High fowlers||||||F
OBX|317|CE|Nu00015600^Patient's position during lunch^ADM||2^Edge of bed||||||F
OBX|318|CE|Nu00015700^Patient's position during dinner^ADM||3^Bedside chair||||||F
OBX|319|CE|NuBRAMCO02^Breakfast amount consumed^ADM||02^25%||||||F
OBX|320|CE|NuDIAMCO02^Dinner amount consumed^ADM||04^75%||||||F
OBX|321|TX|NuIN000150^Last solid food intake date^ADM||20180801||||||F
OBX|322|TX|NuIN000200^Last oral intake solids time^ADM||1027||||||F
OBX|323|TX|NuIN000350^Last fluid intake date^ADM||20180801||||||F
OBX|324|TX|NuIN000400^Last oral intake fluids time^ADM||1027||||||F
OBX|325|CE|NuLUAMCO02^Lunch amount consumed^ADM||03^50%||||||F
OBX|326|TX|NuNICUF370^Intake, Oral Amount^ADM||500.0||||||F
OBX|327|TX|NuNICUFE91^Mother's EBM amount^ADM||55.0||||||F
OBX|328|CE|NuONSOUR00^Oral nutrition food source^ADM||1^Hospital||||||F
OBX|329|TX|NuPEDFEE00^Diet type^ADM||regular||||||F
OBX|330|TX|NuPEDFEE51^Oral intake description^ADM||juice||||||F
OBX|331|TX|NuPNCYSC01^Parenteral nutrition cycling delivery schedule^ADM||TID||||||F
OBX|332|CE|NuSNAMCO02^Snack amount consumed^ADM||04^75%||||||F
OBX|333|CE|OEISO^Infection Control:^ADM||C^Contact||||||F
OBX|334|CE|Oh00000600^Sleep environment^ADM||1^Incubator||||||F
OBX|335|TX|Oh00000700^Sleep environment other^ADM||seizure pads on sides||||||F
OBX|336|TX|OhMEDREC00^Medication reconciliation form completed^ADM||Y||||||F
OBX|337|TX|OhPROCTO00^Patient's tolerance of procedure comment^ADM||super||||||F
OBX|338|CE|PaFINN0000^Cry^ADM||1^Excessive cry (2)||||||F
OBX|339|CE|PaFINN0010^Sleep^ADM||2^< 2 hrs post feed (2)||||||F
OBX|340|CE|PaFINN0020^Moro reflex^ADM||1^Hyperactive (2)||||||F
OBX|341|CE|PaFINN0041^Increased muscle tone^ADM||1^Yes (2)||||||F
OBX|342|CE|PaFINN0051^Excoriation^ADM||1^Yes (1)||||||F
OBX|343|TX|PaFINN0060^Excoriation comment^ADM||bilateral arms||||||F
OBX|344|CE|PaFINN0071^Myoclonic jerks^ADM||1^Yes (3)||||||F
OBX|345|CE|PaFINN0081^Generalized convulsions^ADM||1^Yes (5)||||||F
OBX|346|CE|PaFINN0091^Sweating^ADM||1^Yes (1)||||||F
OBX|347|CE|PaFINN0100^Fever^ADM||1^37.2 - 38.3 C (1)||||||F
OBX|348|CE|PaFINN0111^Frequent yawning^ADM||1^Yes (1)||||||F
OBX|349|CE|PaFINN0121^Mottling^ADM||1^Yes (1)||||||F
OBX|350|CE|PaFINN0131^Nasal stuffiness^ADM||1^Yes (1)||||||F
OBX|351|CE|PaFINN0141^Sneezing^ADM||1^Yes (1)||||||F
OBX|352|CE|PaFINN0151^Nasal flaring^ADM||1^Yes (2)||||||F
OBX|353|CE|PaFINN0160^Respiratory rate^ADM||2^With retractions (2)||||||F
OBX|354|CE|PaFINN0171^Excessive sucking^ADM||1^Yes (1)||||||F
OBX|355|CE|PaFINN0181^Poor feeding^ADM||1^Yes (2)||||||F
OBX|356|CE|PaFINN0191^Regurgitation^ADM||1^Yes (2)||||||F
OBX|357|CE|PaFINN0201^Projectile vomiting^ADM||1^Yes (3)||||||F
OBX|358|CE|PaFINN0211^Loose stools^ADM||1^Yes (2)||||||F
OBX|359|CE|PaFINN0221^Watery stools^ADM||1^Yes (3)||||||F
OBX|360|TX|PaFINN0230^Neonatal Abstinence Score^ADM||45||||||F
OBX|361|CE|PaFINN0240^Tremors disturbed^ADM||2^Moderate-severe (2)||||||F
OBX|362|CE|PaFINN0250^Tremors undisturbed^ADM||1^Mild (3)||||||F
OBX|363|TX|PaNBCATH00^Catheter distal tip intact with removal^ADM||Y||||||F
OBX|364|TX|PaPATEXP00^Patient experiencing pain^ADM||N||||||F
OBX|365|CE|PaPSADEV04^Procedural sedation adverse events^ADM||1^None||||||F
OBX|366|TX|PhDBLCHK00^Double check by^ADM||Sarah, RN||||||F
OBX|367|TX|Ps00000100^Percentage intelligible to unfamiliar listener^ADM||56||||||F
OBX|368|CE|PsCLCONS01^Special considerations^ADM||1^Family visiting||||||F
OBX|369|TX|PsCLCOPE00^Coping mechanisms^ADM||rocking||||||F
OBX|370|TX|PsCLHOOT00^Reactions  to hospitalization/Illness other^ADM||Fear||||||F
OBX|371|CE|PsCLHOSP00^Reactions to hospitalization/Illness^ADM||1^Difficulty coping||||||F
OBX|372|CE|PsCLINTE00^Interventions^ADM||1^Medical play||||||F
OBX|373|TX|PsCLIRCC00^Consent comments^ADM||test consent comment||||||F
OBX|374|CE|PsCLIRCO00^Consent obtained for child life involvement^ADM||1^Yes||||||F
OBX|375|CE|PsCRAFAL00^Ever use alcohol/ drugs while you are by yourself/ALONE^ADM||1^No||||||F
OBX|376|CE|PsCRAFAN01^Did the patient answer 0 for all questions in Part A^ADM||1^No||||||F
OBX|377|CE|PsCRAFCA00^Ever ridden in a CAR driven by someone who was high^ADM||1^No||||||F
OBX|378|TX|PsCRAFDA00^In PAST 12 Mos, how many days did you drink alcohol^ADM||6||||||F
OBX|379|CE|PsCRAFFA00^Do FAM/FRIENDS ever tell you to cut down drugs/alcohol^ADM||2^Yes||||||F
OBX|380|CE|PsCRAFFO00^Ever FORGET things you did while using alcohol or drugs^ADM||2^Yes||||||F
OBX|381|TX|PsCRAFHI00^In PAST 12 Mos, how many days did use anything to get high^ADM||0||||||F
OBX|382|TX|PsCRAFMA00^In PAST 12 Mos, how many days did you use marijuana^ADM||0||||||F
OBX|383|CE|PsCRAFRE00^Do you ever use alcohol or drugs to RELAX^ADM||2^Yes||||||F
OBX|384|TX|PsCRAFTO01^CRAFFT Score Total (Part B)^ADM||3||||||F
OBX|385|CE|PsCRAFTR00^Ever gotten into TROUBLE while using alcohol/drugs^ADM||1^No||||||F
OBX|386|TX|PsHESH0000^Home environment - smoking in home^ADM||Y||||||F
OBX|387|TX|PsPROGGO00^Goals^ADM||goals||||||F
OBX|388|TX|PsPROGNT00^Progress notes^ADM||progress notes||||||F
OBX|389|TX|PsPVALOT00^Perceptual voice assessment - loudness other^ADM||TEST||||||F
OBX|390|CE|PsPVALOU00^Perceptual voice assessment - loudness^ADM||3^Severely soft/quiet~6^Excessive variation||||||F
OBX|391|CE|PsPVAPIT00^Perceptual voice assessment - pitch^ADM||2^Limited variation~11^Mildly low||||||F
OBX|392|CE|PsRESONA00^Speech resonance^ADM||2^Hyponasal~4^Impairments noted~5^Hypernasal||||||F
OBX|393|CE|PsSARTIC00^Articulation^ADM||1^Within functional limits~3^Vowel distortion~7^Cluster reduction||||||F
OBX|394|TX|PsSARTIO00^Articulation other^ADM||TES||||||F
OBX|395|TX|PsSARTPS00^Articulation comment^ADM||TESt||||||F
OBX|396|TX|PsSECOMM00^Professional/Service contacts comments^ADM||rest||||||F
OBX|397|CE|PsSECONT00^Professional/Service contacts^ADM||14^School district||||||F
OBX|398|TX|PsSINTCM01^Intelligibility comment^ADM||TEST||||||F
OBX|399|CE|PsSINTEC00^Intelligibility - conversation^ADM||2^Reduced||||||F
OBX|400|CE|PsSINTES00^Intelligibility - sentence^ADM||1^Within functional limits||||||F
OBX|401|CE|PsSINTEW00^Intelligibility - word^ADM||1^Within functional limits||||||F
OBX|402|CE|PsSLP06000^Additional phonation observations^ADM||2^Above avg voice use||||||F
OBX|403|TX|PsSLP06100^Additional phonation observations other^ADM||TEST||||||F
OBX|404|CE|PsSLP07000^Posture entire body^ADM||1^Neutral||||||F
OBX|405|TX|PsSLP07100^Posture entire body comment^ADM||TESTE||||||F
OBX|406|TX|PsSLP08100^Posture neck comment^ADM||TESET||||||F
OBX|407|TX|PsSPROCM00^Prosody comment^ADM||TEST||||||F
OBX|408|TX|PsSPROOO00^Speech - Prosody Other^ADM||TESTE||||||F
OBX|409|CE|PsSPROSO00^Prosody^ADM||1^Within functional limits~5^Pitch breaks~10^Variable rate||||||F
OBX|410|TX|PsSRESON00^Speech resonance other^ADM||TEST||||||F
OBX|411|TX|PsSRESONC0^Speech resonance comments^ADM||TEST||||||F
OBX|412|TX|PsSRESPC00^Respiration comment^ADM||test||||||F
OBX|413|CE|PsSRESPI00^Respiration^ADM||2^Forced inspiration~6^Forced exhalation~7^Shallow breathing||||||F
OBX|414|TX|PsSRESPO00^Respiration other^ADM||TEST||||||F
OBX|415|TX|PsSWSTLB00^Language barrier^ADM||N||||||F
OBX|416|CE|PsSWSTLG00^Legal guardian^ADM||1^Mother(s)~2^Father(s)||||||F
OBX|417|TX|PsSWSTRO00^Reason for referral other^ADM||pain mgmt||||||F
OBX|418|TX|PsVELMTC01^Extralaryngeal muscle tension comments^ADM||TESt||||||F
OBX|419|CE|PsVELMTE00^Extralaryngeal muscle tension^ADM||1^Within functional limits||||||F
OBX|420|TX|ReAENTRY00^Air entry adequate throughout^ADM||Y||||||F
OBX|421|CE|ReAUBTHS02^Breath sounds^ADM||4^Fine~6^Crackles||||||F
OBX|422|CE|ReAULOCT00^Auscultation location^ADM||7^Left lung||||||F
OBX|423|CE|ReAULOMO00^Auscultation location modifier^ADM||2^Posterior||||||F
OBX|424|TX|ReAWISDT00^Date inline suction catheter initiated or changed^ADM||20180719||||||F
OBX|425|TX|ReBCLEAR00^Breath sounds clear throughout^ADM||Y||||||F
OBX|426|TX|ReBR001300^Bronchoscopy lidocaine spray number of applications^ADM||8||||||F
OBX|427|CE|ReCGDESC01^Cough description^ADM||1^Normal||||||F
OBX|428|TX|ReCGDESO00^Cough description other^ADM||wet||||||F
OBX|429|CE|ReCGSTGH00^Cough strength^ADM||1^Strong||||||F
OBX|430|CE|ReCOLMET01^Secretions collection method^ADM||1^Closed/Inline suction||||||F
OBX|431|CE|ReCOLMET03^Suctioning method^ADM||3^Yankauer||||||F
OBX|432|TX|ReCT000301^Chest tubes type^ADM||pigtail||||||F
OBX|433|TX|ReCT000400^Chest tubes size^ADM||8||||||F
OBX|434|TX|ReCT001001^Chest tubes drainage system^ADM||thopaz||||||F
OBX|435|CE|ReCT001100^Chest tubes drainage method^ADM||1^Suction||||||F
OBX|436|TX|ReCT001201^Chest tubes suction level^ADM||10.0||||||F
OBX|437|TX|ReCT001300^Chest tube clamped^ADM||N||||||F
OBX|438|TX|ReCT001500^Chest tube clamp air leak present^ADM||N||||||F
OBX|439|TX|ReCT001800^Subcutaneous emphysema present^ADM||N||||||F
OBX|440|CE|ReCT002101^Chest tube drainage description^ADM||2^Serosanguineous||||||F
OBX|441|TX|ReCT002901^Chest tube system tubing patent/connections secure^ADM||Y||||||F
OBX|442|CE|ReCT005000^Chest tube safety equipment^ADM||2^2 smooth-edged clamps~3^4x4 occlusive dressing~4^4x4 gauze||||||F
OBX|443|TX|ReCTDATE00^Chest tube insertion date^ADM||20180822||||||F
OBX|444|CE|ReCTLOCM00^Chest tubes insertion site modifier^ADM||1^Right||||||F
OBX|445|CE|ReCTLOCN00^Chest tubes insertion site^ADM||1^Posterior||||||F
OBX|446|TX|ReDESCOM00^Description other^ADM||tenacious||||||F
OBX|447|TX|ReEXVEPA01^Volume epinephrine administered^ADM||2.5||||||F
OBX|448|TX|ReFRINOX01^Fraction of inspired oxygen (FiO2)^ADM||0.21||||||F
OBX|449|TX|ReINLINE02^Inline suction catheter change due date^ADM||26 July 2018||||||F
OBX|450|TX|ReMEDS0000^Salbutamol dose^ADM||2.00||||||F
OBX|451|CE|ReMEDS0100^Salbutamol units^ADM||2^mcg||||||F
OBX|452|TX|ReMEDS0200^Ipratropium bromide dose^ADM||4.00||||||F
OBX|453|CE|ReMEDS0300^Ipratropium bromide units^ADM||1^mcg||||||F
OBX|454|TX|ReMEDS0400^Fluticasone dose^ADM||1.00||||||F
OBX|455|CE|ReMEDS0500^Fluticasone units^ADM||1^mcg||||||F
OBX|456|TX|ReMEDS0600^Budesonide dose^ADM||3.00||||||F
OBX|457|CE|ReMEDS0700^Budesonide units^ADM||2^mcg||||||F
OBX|458|TX|ReMEDS0800^Surfactant number of aliquots^ADM||5||||||F
OBX|459|TX|ReMEDS0900^Lidocaine 4% via cuff^ADM||7.0||||||F
OBX|460|TX|ReMEDS1000^Volume epinephrine administered^ADM||1.0||||||F
OBX|461|TX|ReNEEQSC05^Safety equipment checked^ADM||Y||||||F
OBX|462|TX|ReNETTSU01^Suction depth^ADM||blue||||||F
OBX|463|TX|ReNETTSW01^Suction depth warning^ADM||red||||||F
OBX|464|CE|ReNRDISI02^Respiratory distress indicators^ADM||10^Audible stridor||||||F
OBX|465|CE|ReOXYTHE05^Oxygen therapy delivery method^ADM||16^Heated low flow cannula||||||F
OBX|466|CE|ReOXYUOM00^Oxygen units of measure^ADM||1^L/min||||||F
OBX|467|CE|RePED00200^Respiratory interventions^ADM||1^Deep breathing||||||F
OBX|468|CE|ReRECHEX01^Chest expansion^ADM||1^Symmetrical||||||F
OBX|469|CE|ReREDPTH00^Respiratory depth^ADM||1^Normal||||||F
OBX|470|TX|ReREMECO01^Other respiratory medication comments^ADM||nothing||||||F
OBX|471|CE|ReRPNM0000^Respiratory pattern^ADM||1^Normal||||||F
OBX|472|CE|ReSCAMNT00^Secretions amount^ADM||2^Small||||||F
OBX|473|CE|ReSCCOLR00^Secretions colour^ADM||1^Clear||||||F
OBX|474|TX|ReSCCOMM00^Secretions comment^ADM||sec comments||||||F
OBX|475|CE|ReSCDESC02^Secretions description^ADM||1^Mucoid||||||F
OBX|476|TX|ReSCSPSN00^Specimen sent^ADM||Y||||||F
OBX|477|CE|ReSE000100^Secretion source^ADM||2^Tracheostomy||||||F
OBX|478|CE|ReSE000102^Secretions source^ADM||7^Oral cavity||||||F
OBX|479|TX|ReSECMET00^Secretions collection method other^ADM||and expectorated||||||F
OBX|480|CE|ReSECOMT00^Secretions collection method^ADM||1^Suctioned||||||F
OBX|481|CE|ReSFADMT02^Surfactant route of administration^ADM||3^Direct installation||||||F
OBX|482|TX|ReSFAMNT00^Surfactant amount^ADM||3||||||F
OBX|483|TX|ReSFDOSE01^Surfactant treatment number^ADM||1||||||F
OBX|484|TX|ReSFLOTN01^Surfactant lot number^ADM||1234||||||F
OBX|485|TX|ReSUCCOM00^Suctioning comments^ADM||nothing else||||||F
OBX|486|CE|ReVE009103^Ventilation medications salbutamol administration^ADM||1^2.5 mg nebule||||||F
OBX|487|CE|ReVE009304^Ventilation medications ipratropium bromide admin^ADM||1^250 mcg nebule||||||F
OBX|488|TX|ReVE009310^Bronchodilators other^ADM||bronch other nicy||||||F
OBX|489|CE|ReVE009601^Adult ventilation medications budesonide administration^ADM||1^0.5 mg nebule||||||F
OBX|490|TX|ReVE009710^Inhaled corticosteroids other^ADM||cortico other nicy||||||F
OBX|491|CE|ReVE009807^Bronchodilators route of administration^ADM||2^BIPAP circuit||||||F
OBX|492|CE|ReVE009809^Corticosteroid route of administration^ADM||2^BIPAP circuit||||||F
OBX|493|CE|ReVE009811^Other medications route of administration^ADM||6^Vibrating mesh nebulizer||||||F
OBX|494|TX|ReVE009830^Aerosolized medication other^ADM||aero meds other||||||F
OBX|495|TX|ReVE009900^Adult ventilation medications lidocaine 1% given ETT/trach^ADM||6.0||||||F
OBX|496|TX|ReVE010000^Adult ventilation medications lidocaine 4% given ETT/trach^ADM||4.0||||||F
OBX|497|CE|ReWRKBRE00^Work of breathing^ADM||1^Normal||||||F
OBX|498|TX|RpBLDL0100^Output, Blood Loss Amount^ADM||250.00||||||F
OBX|499|TX|RpBLDL0200^Postpartum hemorrhage comments^ADM||3 pads||||||F
OBX|500|CE|RpBLDL0300^Estimated blood loss^ADM||1^less than 500mL||||||F
OBX|501|CE|RpDE000100^Delivery type^ADM||1^SVD||||||F
OBX|502|TX|RpDE000400^Delivery date^ADM||20180728||||||F
OBX|503|CE|RpFU000100^Fundus location^ADM||2^Deviated right||||||F
OBX|504|CE|RpFU000301^Fundus tone^ADM||1^Firm||||||F
OBX|505|CE|RpFUNHEI00^Fundal height^ADM||1^Umbilicus||||||F
OBX|506|TX|RpME000100^Date of last menses^ADM||20180728||||||F
OBX|507|CE|RpONGOB001^Head and neck defined parameters^ADM||1^Within defined parameters||||||F
OBX|508|CE|RpONGOI021^Eyes defined parameters^ADM||1^Within defined parameters||||||F
OBX|509|CE|RpONGOI041^Ears defined parameters^ADM||1^Within defined parameters||||||F
OBX|510|CE|RpONGOI071^Nose defined parameters^ADM||2^Significant findings||||||F
OBX|511|CE|RpONGOI101^Oral defined parameters^ADM||1^Within defined parameters||||||F
OBX|512|CE|RpPERCM001^Perineum comfort measures used^ADM||1^Ice pack~2^Tea pads||||||F
OBX|513|CE|RpPERCON01^Perineum condition^ADM||2^Tenderness||||||F
OBX|514|CE|RpRPASSE00^Lochia amount^ADM||1^Nil||||||F
OBX|515|CE|RpRPASSE11^Lochia description^ADM||2^Serosa||||||F
OBX|516|TX|RpRPASSE20^Lochia description other^ADM||alba||||||F
OBX|517|TX|RpRPASSE30^Clots present^ADM||N||||||F
OBX|518|CE|RpRPASSE40^Lochia odour^ADM||1^None||||||F
OBX|519|TX|RpRPASSE50^Lochia comments^ADM||lochia comments||||||F
OBX|520|TX|RpSHXSAC00^Sexually active^ADM||N||||||F
OBX|521|TX|RpSYSCOM00^Other reproductive system comments^ADM||other comments||||||F
OBX|522|CE|RpUC001300^Umbilical cord fetal cord vessel number^ADM||1^3||||||F
OBX|523|TX|Sp00000000^Alarm limits set^ADM||Y||||||F
OBX|524|TX|Sp00000100^Infusion concentrations and pump settings reviewed^ADM||Y||||||F
OBX|525|TX|SpBASFAL00^Injuries sustained from fall^ADM||pt tried to get up from chair and fell to floor||||||F
OBX|526|TX|SpCONSNT00^Consent confirmed^ADM||Y||||||F
OBX|527|TX|SpCYTOME00^Receiving cytotoxic medication^ADM||N||||||F
OBX|528|TX|SpDENTUR00^Dentures removed^ADM||Y||||||F
OBX|529|TX|SpFALWIT00^Fall witnessed^ADM||Y||||||F
OBX|530|CE|SpFASETF01^Fall safety equipment in use at time of fall^ADM||2^Proper non-slip footwear||||||F
OBX|531|TX|SpFUWOHI00^Follow-up initiated for witnessed fall without head injury^ADM||Y||||||F
OBX|532|TX|SpHENEIN00^Concerns re: possible head and/or neck injury^ADM||Y||||||F
OBX|533|TX|SpIDCHEK00^ID band checked^ADM||Y||||||F
OBX|534|TX|SpINJFAL00^Other injuries sustained in fall^ADM||N||||||F
OBX|535|CE|SpINTRI000^Oral intubation risk assessment^ADM||1^Dentures||||||F
OBX|536|CE|SpIPRATI03^Isolation precautions rationale suspected/confirmed ED^ADM||19^Foreign travel||||||F
OBX|537|CE|SpIPRTYP00^Isolation precautions room type^ADM||2^Single occupancy room||||||F
OBX|538|TX|SpJEWEL000^Jewellery removed or secured^ADM||Y||||||F
OBX|539|TX|SpORNEIN00^Concerns re: orthopedic/neurovascular injury^ADM||N||||||F
OBX|540|TX|SpPFPANC01^On anticoagulant therapy^ADM||Y||||||F
OBX|541|TX|SpPOVINI00^Follow-up initiated for possible vascular injury^ADM||Y||||||F
OBX|542|TX|SpPRPERF00^Practitioner performing^ADM||Dr. Brown||||||F
OBX|543|TX|SpRADIAT00^Receiving radiation^ADM||N||||||F
OBX|544|TX|SpRADPRE00^Radiation precautions required^ADM||N||||||F
OBX|545|TX|SpRIREQU00^Reverse isolation required^ADM||N||||||F
OBX|546|TX|SpTCNICU01^Ordered total fluid intake^ADM||100||||||F
OBX|547|CE|SpTCNICU10^Ordered dosing weight source^ADM||1^Birth weight||||||F
OBX|548|TX|SpTCNICU21^Dosing weight for calculation^ADM||0.200||||||F
OBX|549|TX|SpTCNICU31^Calculated total fluid intake required^ADM||0.83||||||F
OBX|550|TX|SpTCNICU41^Actual fluid intake amount^ADM||0.80||||||F
OBX|551|TX|SpTCNICU50^Actual fluid intake received per hour^ADM||0.20 mL/hour over 4 hours||||||F
OBX|552|TX|SpTCNICU60^Actual fluid intake interval^ADM||4||||||F
OBX|553|TX|SpTCNICU70^Actual total fluid intake received^ADM||Estimated 24 mL/kg/day based on past 4 hours||||||F
OBX|554|TX|SpTIMEFD00^Time fall discovered/occurred^ADM||1015||||||F
OBX|555|TX|SpTRAMAT10^Universal falls precautions in place^ADM||Y||||||F
OBX|556|TX|SpTRAMAT40^Other transition of care comments^ADM||other comments for TOC peds||||||F
OBX|557|TX|SpTRANS220^Handover given by^ADM||Jill RN||||||F
OBX|558|TX|SpTRANS230^Handover received by^ADM||Jane RN||||||F
OBX|559|TX|SpTRANS270^Bedside suction level^ADM||20||||||F
OBX|560|TX|SpTRANS280^T-piece resuscitator max pressure^ADM||50||||||F
OBX|561|TX|SpTRANS290^T-piece resuscitator PIP^ADM||55||||||F
OBX|562|TX|SpTRANS300^T-piece resuscitator PEEP/CPAP^ADM||60||||||F
OBX|563|TX|SpTRANS310^Other transition of care comments^ADM||testing other toc comments for NICU||||||F
OBX|564|TX|SpTRANS330^Infusion concentrations and pump settings reviewed^ADM||Y||||||F
OBX|565|TX|SpTRANS340^Patient identification number programmed into IV pump(s)^ADM||Y||||||F
OBX|566|TX|SpTRANSI10^Patient identifiers^ADM||Y||||||F
OBX|567|TX|SpTRANSI51^Neonatal universal falls precautions in place^ADM||Y||||||F
OBX|568|CE|SpTRANSI60^Manual resuscitator type^ADM||2^Self inflating||||||F
OBX|569|TX|SpTRANSI71^Blender fraction of inspired oxygen^ADM||0.21||||||F
OBX|570|TX|SpTRANSI90^Transition to safe sleep initiated date^ADM||20180725||||||F
OBX|571|TX|TeEDINTR00^Interpreter utilized^ADM||N||||||F
OBX|572|CE|TeEDMATP01^Learning materials provided^ADM||1^Handout/Pamphlet||||||F
OBX|573|TX|VsBEDHUM00^Bed humidity^ADM||50||||||F
OBX|574|TX|VsBEDTEM00^Bed temperature^ADM||38.0||||||F
OBX|575|CE|VsBPCFLP01^Blood pressure cuff location^ADM||2^Right leg||||||F
OBX|576|CE|VsBPDEUS00^Device used^ADM||1^Automated cuff||||||F
OBX|577|TX|VsBPDIAO03^Blood pressure diastolic^ADM||80||||||F
OBX|578|TX|VsBPMAPA05^Blood pressure mean arterial pressure^ADM||90||||||F
OBX|579|TX|VsBPSYSO03^Blood pressure systolic^ADM||160||||||F
OBX|580|TX|VsDAPRWT00^Date of previous weight^ADM||20180727||||||F
OBX|581|TX|VsHECIRC00^Head circumference^ADM||12.0||||||F
OBX|582|TX|VsHRADLT04^Pulse rate^ADM||130||||||F
OBX|583|CE|VsHRMETH00^Heart rate method used^ADM||4^Monitor||||||F
OBX|584|CE|VsHRRHYM02^Pulse rhythm^ADM||1^Regular||||||F
OBX|585|TX|VsHTCM0100^Current height^ADM||25.0||||||F
OBX|586|TX|VsOXDRAD02^Oxygen therapy delivery rate^ADM||2||||||F
OBX|587|TX|VsPOOSAD02^Pulse oximetry oxygen saturation^ADM||99||||||F
OBX|588|CE|VsPRBLOC00^Probe location^ADM||4^Foot||||||F
OBX|589|CE|VsPRLOMO00^Probe location modifier^ADM||1^Right||||||F
OBX|590|CE|VsPULSTR00^Pulse strength on palpation^ADM||2^Moderate||||||F
OBX|591|TX|VsRESPAD04^Respiratory rate^ADM||22||||||F
OBX|592|CE|VsTPSORC01^Temperature source^ADM||2^Skin probe||||||F
OBX|593|TX|VsTPTEMPO4^Temperature^ADM||36.6||||||F
OBX|594|TX|VsWT000101^Current Weight^ADM||0.150||||||F
OBX|595|CE|VsWT000700^Weight measurement method^ADM||1^Standing scale||||||F
OBX|596|TX|VsWT001500^Dosing weight^ADM||70.0||||||F
OBX|597|TX|VsWT001701^Birth weight^ADM||0.010||||||F
OBX|598|TX|VsWT005000^Birth height or length^ADM||10.00||||||F
OBX|599|TX|VsWT007700^Birth head circumference^ADM||10.00||||||F
OBX|600|TX|VsWTGRAM00^Weight (Calculated Grams)^ADM||2100.000||||||F
OBX|601|TX|VsWTPREV02^Previous weight^ADM||2.000||||||F
OBX|602|CE|ylLINETYP2^Line Type^ADM||3^CVC||||||F
OBX|603|CE|ylSOLUM01^Solution^ADM||1^NS||||||F
OBX|604|TX|ADM WCB^IS THIS VISIT RELATED TO A WCB CLAIM?^INS||N||||||F
ZFD|OEDOCM^Oedoc^Marytrain^^^^MD^50003^DOC|9876 Main Street^^Surrey^BC^V3V 1Z1|||OEDOCM^Oedoc^Marytrain^^^^MD^50003^DOC|OEDOCM^Oedoc^Marytrain^^^^MD^50003^DOC|
ZFH|LUMED|||||||||NMIHGTWGT

